Stay updated on Venetoclax and Dinaciclib in AML Clinical Trial
Sign up to get notified when there's something new on the Venetoclax and Dinaciclib in AML Clinical Trial page.

Latest updates to the Venetoclax and Dinaciclib in AML Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedA new revision tag Revision: v3.5.4 is displayed, replacing Revision: v3.5.3, indicating a platform release update. This change does not modify the study data or how users access the page.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedThe page’s interface/version footer was updated from Revision v3.5.2 to v3.5.3, reflecting a software release rather than any change to the clinical study details.SummaryDifference0.1%

- Check49 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check78 days agoChange DetectedAdded site revision note: v3.5.0; removed revision: v3.4.3.SummaryDifference0.1%

- Check85 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check114 days agoChange DetectedAdded Revision: v3.4.2; removed the previous funding-status notice (lapse in government funding) and Revision: v3.4.1.SummaryDifference0.4%

Stay in the know with updates to Venetoclax and Dinaciclib in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax and Dinaciclib in AML Clinical Trial page.